作者
Xiang Ma,Jing Wang,Yuhua Shi,Jichun Tan,Yichun Guan,Yun Sun,Bo Zhang,Junli Zhao,Jianqiao Liu,Yunxia Cao,Hong Li,Cuilian Zhang,Feng Chen,Honggang Yi,Li Wang,Xing Xin,Pingping Kong,Yao Lu,Ling Huang,Yingying Yuan,Haiying Liu,Caihua Li,Ben W. Mol,Zhibin Hu,Heping Zhang,Zi‐Jiang Chen,Jiayin Liu
摘要
In this multicenter, non-inferiority, randomized trial, we randomly assigned 992 women undergoing in-vitro fertilization (IVF) with a good prognosis (aged 20-40, ≥3 transferrable cleavage-stage embryos) to strategies of blastocyst-stage (n = 497) or cleavage-stage (n = 495) single embryo transfer. Primary outcome was cumulative live-birth rate after up to three transfers. Secondary outcomes were cumulative live-births after all embryo transfers within 1 year of randomization, pregnancy outcomes, obstetric-perinatal complications, and livebirths outcomes. Live-birth rates were 74.8% in blastocyst-stage group versus 66.3% in cleavage-stage group (relative risk 1.13, 95%CI:1.04-1.22; P